Bruker Corporation (BRKR) announces the appointment of Thierry Bernard to serve on its Board of Directors, effective as of today. Bernard currently serves as Chief Executive Officer of QIAGEN (QGEN).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- PreOmics, Biognosys announces ‘favorable’ outcome in U.S. patent challenge
- Bruker price target lowered to $50 from $58 at Guggenheim
- PTAB upholds Seer patent for nano- and microparticles in challenge by Bruker
- Rising helium prices could create headwind for Bruker, says Jefferies
- Bruker Announces Board Changes and Declares Quarterly Dividend